Literature DB >> 25771691

Commentary on Burns et al. (2015): retention in buprenorphine treatment.

Andrew J Saxon1.   

Abstract

Entities:  

Keywords:  Buprenorphine; medication assisted treatment; methadone; opioid use disorder; pharmacogenetics; treatment retention

Mesh：

Substances：

Year:  2015        PMID： 25771691      PMCID： PMC4367122          DOI： 10.1111/add.12865

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  18 in total

Review 1.  Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.

Authors:  Louisa Degenhardt; Chiara Bucello; Bradley Mathers; Christina Briegleb; Hammad Ali; Matt Hickman; Jennifer McLaren
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

2.  Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; David A Fiellin; Marilyn Byrne; Hilary S Connery; William Dickinson; John Gardin; Margaret L Griffin; Marc N Gourevitch; Deborah L Haller; Albert L Hasson; Zhen Huang; Petra Jacobs; Andrzej S Kosinski; Robert Lindblad; Elinore F McCance-Katz; Scott E Provost; Jeffrey Selzer; Eugene C Somoza; Susan C Sonne; Walter Ling
Journal:  Arch Gen Psychiatry       Date:  2011-11-07

3.  Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

Authors:  David A Fiellin; Michael V Pantalon; Marek C Chawarski; Brent A Moore; Lynn E Sullivan; Patrick G O'Connor; Richard S Schottenfeld
Journal:  N Engl J Med       Date:  2006-07-27       Impact factor: 91.245

Review 4.  Maintenance medication for opiate addiction: the foundation of recovery.

Authors:  Gavin Bart
Journal:  J Addict Dis       Date:  2012

Review 5.  Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.

Authors:  Linda R Gowing; Michael Farrell; Reinhard Bornemann; Lynn E Sullivan; Robert L Ali
Journal:  J Gen Intern Med       Date:  2005-12-07       Impact factor: 5.128

6.  An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.

Authors:  Richard C Crist; Toni-Kim Clarke; Alfonso Ang; Lisa M Ambrose-Lanci; Falk W Lohoff; Andrew J Saxon; Walter Ling; Maureen P Hillhouse; R Douglas Bruce; George Woody; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

7.  The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.

Authors:  L A Marsch
Journal:  Addiction       Date:  1998-04       Impact factor: 6.526

8.  Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.

Authors:  K L Sees; K L Delucchi; C Masson; A Rosen; H W Clark; H Robillard; P Banys; S M Hall
Journal:  JAMA       Date:  2000-03-08       Impact factor: 56.272

9.  Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.

Authors:  Janet M Soeffing; L David Martin; Michael I Fingerhood; Donald R Jasinski; Darius A Rastegar
Journal:  J Subst Abuse Treat       Date:  2009-06-23

10.  Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database.

Authors:  Rosie Cornish; John Macleod; John Strang; Peter Vickerman; Matt Hickman
Journal:  BMJ       Date:  2010-10-26
View more
  2 in total

1.  Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province.

Authors:  Joseph Sadek; Joseph Saunders
Journal:  BMC Psychiatry       Date:  2022-07-30       Impact factor: 4.144

2.  Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada.

Authors:  Micah Piske; Trevor Thomson; Emanuel Krebs; Natt Hongdilokkul; Julie Bruneau; Sander Greenland; Paul Gustafson; M Ehsan Karim; Lawrence C McCandless; Malcolm Maclure; Robert W Platt; Uwe Siebert; M Eugenia Socías; Judith I Tsui; Evan Wood; Bohdan Nosyk
Journal:  BMJ Open       Date:  2020-09-09       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.